 Inovio Pharmaceuticals Inc. NASDAQ:INO shares are trading higher Thursday after the company announced it received regulatory authorization from Brazils ANVISA to initiate the global Phase 3 segment of its Phase 23 trial for INO-4800. Inovio Pharmaceuticals stock was up 9.3 at 9.22 at last check. 